Journal ArticleDOI
Cutaneous manifestations of breast carcinoma.
Vincenzo De Giorgi,Marta Grazzini,Barbara Alfaioli,Imma Savarese,Suzana Alexandra Corciova,Giuseppe Guerriero,Torello Lotti +6 more
Reads0
Chats0
TLDR
The most common sites of breast carcinoma cutaneous manifestation are the chest wall and abdomen, but they can occur at the extremities and in the head/neck region.Abstract:
The incidence of breast carcinoma cutaneous manifestation in patients with breast carcinoma is 23.9%. The most common sites of breast carcinoma cutaneous manifestation are the chest wall and abdomen, but they can occur at the extremities and in the head/neck region. Due the high incidence of breast carcinoma, these cutaneous manifestations are the most common metastases seen by dermatologists. In clinical practice, cutaneous metastases show a wide range of clinical manifestations. Nodules are the most common presentation, but several other patterns are described below.read more
Citations
More filters
Journal ArticleDOI
Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review.
TL;DR: The clinicopathologic and immunohistochemical characteristics of cutaneous metastases from internal malignancies are reviewed, the most common cutaneous cancer metastases are classified, and studies that may assist in diagnosing the origin of aCutaneous metastasis are identified.
Journal ArticleDOI
Electrochemotherapy of chest wall breast cancer recurrence
TL;DR: Electrochemotherapy provides safe, efficient and non-invasive locoregional treatment approach for chest wall breast cancer recurrence and could even be suggested as a primary local therapy in patients not suitable for surgical removal of the primary tumor.
Journal ArticleDOI
Cutaneous manifestations of breast cancer
TL;DR: M Mammary Paget's disease, often associated with an underlying breast cancer, and Cowden syndrome, which has an increased risk of breast malignancy, each have specific dermatologic findings.
Journal ArticleDOI
Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably?
Mark J. Mentrikoski,Mark R. Wick +1 more
TL;DR: It is suggested that p63 and CK5/6 are specific determinants for sweat gland carcinoma in the stated setting and in the absence of those analytes, metastatic breast carcinoma cannot always be identified to the exclusion of a primary tumor.
Journal ArticleDOI
Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience
M.G. Bourke,Slav P. Salwa,Mira Sadadcharam,M.C. Whelan,Patrick F. Forde,J. Larkin,C. Collins,Seamus O'Reilly,Gerald C. O'Sullivan,A. James P. Clover,Declan M. Soden +10 more
TL;DR: Electrochemotherapy is an effective treatment for cutaneous breast cancer lesions that have proven refractory to standard therapies, and smaller lesions were found to be more responsive, suggesting that ECT should be considered as an early treatment modality, within multimodal treatment strategies.
References
More filters
Journal ArticleDOI
Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients
TL;DR: Cutaneous metastases are not uncommon and frequently are the first sign of extranodal metastatic disease, particularly in patients with melanoma, breast cancer, or mucosal cancers of the head and neck.
Journal ArticleDOI
Cutaneous metastatic disease.
TL;DR: Cutaneous metastases represent an opportunity to detect a potentially treatable cancer before other evidence of it is present, to modify therapy as appropriate to the tumor stage, or possibly to use the cutaneous lesion as a source of easily accessible tumor cells for specific therapy.
Journal ArticleDOI
Electrochemotherapy in treatment of tumours.
TL;DR: Electrochemotherapy is a new, clinically acknowledged method for the treatment of cutaneous and subcutaneous tumours whose advantages are high effectiveness on tumours with different histologies, simple application, minimal side effects and the possibility of effective repetitive treatment.
Journal ArticleDOI
Dermatomyositis and malignancy. a review of the literature
B E Barnes,B Mawr +1 more
TL;DR: Although there appears to be an increased incidence of malignancy among patients with dermatomyositis, demonstration of definitive statistical significance is precluded by the lack of large, controlled series.
Journal ArticleDOI
Dermatomyositis and malignancy: a review of the literature
TL;DR: Excerpt Since the original descriptions by Wagner1and Unverricht2 in 1887, dermatomyositis has become a well recognized clinical and pathologic entity.